The Hetero Ring Is Six-membered And Includes At Least Two Nitrogens And No Other Hetero Atoms Patents (Class 514/157)
-
Patent number: 5335675Abstract: A stress-softened thermoplastic elastomeric (TPE) film which has been subjected to tensional deformation comprising at least uniaxial strain, and having improved textural and thermal transmissivity characteristics, as compared to a native, unstretched material. Such stress-softened thermoplastic elastomeric film may be employed in a wide variety of articles, including condoms, finger cots, tubular bandages, and the like. Condoms comprising such stress-softened TPE film are described, including condoms having a main sheath comprising stress-softened and non-stress-softened areas in a pattern or other predetermined arrangement. A variety of methods and apparatus for forming stress-softened tubular articles of thermoplastic elastomeric film is disclosed.Type: GrantFiled: October 11, 1991Date of Patent: August 9, 1994Assignee: Family Health InternationalInventors: Robert G. Wheeler, deceased, William D. Hawley
-
Patent number: 5330980Abstract: A medicament for the topical treatment of burned, irritated, ulcered, chafed, or infected, skin, a method of making the medicament, and a method of use of the medicament, the medicament comprising: about 70.6% by weight of Petrolatum U.S.P.(Vaseline); about 6.8% by weight of Wool Fat U.S.P.; about 4.0% by weight of a Sulfa compounded-ingredient; about 17.4% by weight of Zinc Oxide U.S.P.; and about 1.2% by weight of Disodium Formad Dehyde Sulfoxylate Diamino Diphenyl Sulfone.Type: GrantFiled: August 24, 1992Date of Patent: July 19, 1994Inventor: Jae S. Shin
-
Patent number: 5273970Abstract: The antibacterial substance baquiloprim (2,4-diamino-5-[8-dimethylamino-7-methyl-5-quinolylmethyl]pyrimidine) is shown to be active against protozoal infections, e.g. toxoplasmosis. Preferably the baquiloprim is administered together with a sulphonamide.Type: GrantFiled: January 3, 1991Date of Patent: December 28, 1993Assignee: Coopers Animal Health LimitedInventor: Nicholas McHardy
-
Patent number: 5258373Abstract: Compositions comprising a mixture of the antibiotic frenolicin B with a potentiated sulfonamide anticoccidial agent, useful for the treatment and prevention of coccidiosis in animals and methods of treating coccidiosis are disclosed.Type: GrantFiled: July 17, 1991Date of Patent: November 2, 1993Assignee: Hoffmann-La Roche Inc.Inventors: Eugene G. Schildknecht, Govind G. Untawale
-
Patent number: 5135924Abstract: Systemic bacterial infections caused by aerobic and anaerobic organisms in companion animals such as dogs can be treated effectively and conveniently by the oral administration on a once a day basis of an antibacterial combination of ormetoprim and a sulfonamide, the activity of which is potentiated by ormetoprim. Various dosage forms are possible, including concentrates for addition to the feed or drinking water, as well as boluses, tablets, pastes, solutions, and suspensions for administration directly to the animals.Type: GrantFiled: September 24, 1990Date of Patent: August 4, 1992Assignee: Hoffmann-La Roche Inc.Inventors: Wallace E. Brandt, Lyle J. Hanson, Gianpaolo Maestrone
-
Patent number: 5096896Abstract: A non-crosslinked derivative formable by reacting at least one substituted or unsubstituted, saturated or unsaturated, mono-, di- or poly-carboxy, hydroxy or mercapto hydrocarbon with at least one cyclic unsaturated (thio)ether.Type: GrantFiled: January 10, 1989Date of Patent: March 17, 1992Assignee: National Research Development CorporationInventors: Neil B. Graham, Robert E. Howells, David A. Wood, Koritala P. Rao
-
Patent number: 5063219Abstract: Compositions comprising a mixture of a 2,4-diamino-5-(trisubstituted)benzyl-pyrimidine potentiated sulfonamide antibiotic with an ionophorous polyether anticoccidial agent are useful for the treatment and prevention of coccidiosis in animals.Type: GrantFiled: October 9, 1990Date of Patent: November 5, 1991Assignee: Hoffmann-La Roche Inc.Inventors: Eugene G. Schildknecht, Govind G. Untawale
-
Patent number: 4996198Abstract: Compositions comprising a mixture of a 2,4-diamino-5-(trisubstituted)benzyl-pyrimidine potentiated sulfonamide antibiotic with an ionophorous polyether anticoccidial agent are useful for the treatment and prevention of coccidiosis in animals.Type: GrantFiled: July 11, 1988Date of Patent: February 26, 1991Assignee: Hoffmann-La Roche Inc.Inventors: Eugene G. Schildknecht, Govind G. Untawale
-
Patent number: 4956354Abstract: A therapeutic preparation for the treatment of skin problems. More particularly, the preparation is a mixture including almond oil, sulfathiazole, water and paraffin wax.Type: GrantFiled: December 6, 1988Date of Patent: September 11, 1990Assignees: Thomas G. Kottke, Mary L. KottkeInventor: Gregoria Gutierrez
-
Patent number: 4931433Abstract: Compounds of formula I are formulated with a pharmaceutical carrier for the treatment of neoplastic disease sensitive to treatment with the compounds in animals including humans. ##STR1## wherein: Y is a substituent attached to any of the unsubstituted carbons on the quinoxaline ring selected from NO.sub.2, OCH.sub.3, H, chloro, CH.sub.3, bromo, hydroxy;X is selected from NO.sub.2, NH.sub.2, acylamide; andZ is hydrogen or halo.Type: GrantFiled: May 1, 1987Date of Patent: June 5, 1990Assignee: Merck & Co., Inc.Inventor: Richard L. Tolman
-
Patent number: 4871722Abstract: The invention relates to a synergistic veterinary composition and/or a fodder premix useful for preventing or curing bacterial, fungal and protozoic infection particularly occurring at poultry species. Furthermore the invention relates to a process for preparing same. The composition or premix contains 1 to 100 parts by mass of 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine and/or 1 to 100 parts by mass of 2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine as well as 1 to 100 parts by mass of 2,6-dimethoxy-4-sulfanilamidopyrimidine or a pharmaceutically acceptable salt thereof and 1 to 100 parts by mass of 8-hydroxyquinoline or a pharmaceutically acceptable acid addition salt thereof optionally in admixture with carrier(s) and/or additive(s) commonly used in the pharmaceutical industry or for the preparation of premixes.Type: GrantFiled: February 22, 1988Date of Patent: October 3, 1989Assignee: EGIS GyogyszergvarInventors: Karoly Magyar, Janos Varga, Ferenc Simon, Hedvig Szauder nee Lauko, Pal Fekete, Attila Romvary, Janos Egri, Katalin Zukovics nae Someg
-
Patent number: 4818753Abstract: Compounds of the formula ##STR1## wherein R.sup.1 is H, methyl, ethyl, or chloro and R.sup.2 is hydrocarbyl of 1-12 C are useful as antifungal agents. Compounds of this series wherein R.sup.2 is 7-12 C are novel. A new synthetic method for the compounds is also described.Type: GrantFiled: September 18, 1987Date of Patent: April 4, 1989Assignee: SRI InternationalInventors: William T. Colwell, Joseph I. DeGraw
-
Patent number: 4792551Abstract: Compounds useful for treating inflammation, pain and swelling, represented by the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: Y and Z are each independently halo, alkyl or alkoxy;l and m are each independently integers of 0-4;b is an integer of 2-12; andX is selected from the group consisting of:--NR.sup.1 R.sup.2, --NR.sup.1 (CH.sub.2 CH.sub.2 OH), ##STR2## in which R.sup.1 and R.sup.2 are independently H, alkyl or cycloalkyl;R.sup.3 is H, alkyl or CH.sub.2 CH.sub.2 OH; andn is an integer of 3-7.Type: GrantFiled: July 15, 1983Date of Patent: December 20, 1988Assignee: Syntex (U.S.A.) Inc.Inventors: Peter H. Nelson, Stefan H. Unger, Thomas R. Thieme
-
Patent number: 4781920Abstract: The invention provides physically stable anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole and other anthelmintic compounds in combination with a wide variety of therapeutic agents such as antibiotics, vitamins, vaccines, or mineral supplements.Type: GrantFiled: September 3, 1985Date of Patent: November 1, 1988Assignee: American Cyanamid CompanyInventor: James M. Quinlan
-
Patent number: 4735959Abstract: There are described novel carboxylic acid derivatives of the formula ##STR1## and derivatives of the formula ##STR2## and the addition salts thereof, which exhibit an effect on the intermediary metabolism. Furthermore, the compounds of Formula Ia as well as the compounds of Formula I possess blood-sugar lowering properties.Type: GrantFiled: May 14, 1985Date of Patent: April 5, 1988Assignee: Dr. Karl Thomae GmbHInventors: Wolfgang Grell, Gerhart Griss, Robert Sauter, Rudolf Hurnaus, Eckhard Rupprecht, Nikolaus Kaubisch, Joachim Kahling, Bernhard Eisele
-
Patent number: 4696921Abstract: Mixtures of active substances and pharmaceutical compositions useful in malaria therapy comprising a quinolinemethanol derivative of the formula ##STR1## wherein R.sup.1 is hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl, R.sup.2 is hydrogen, fluorine, chlorine, bromine, methyl or methoxy (at least one of R.sup.1 and R.sup.2 is other than hydrogen), and R.sup.3 is C.sub.1-6 -alkylamino-C.sub.1-3 -alkyl, di-C.sub.1-6 -alkylamino-C.sub.1-3 -alkyl, 2-piperidyl or 3-piperidyl, or a pharmaceutically acceptable acid addition salt thereof; a compound which acts as a p-aminobenzoic acid antagonist; and a compound which acts as a dihydrofolic acid reductase inhibitor, are described.Type: GrantFiled: November 7, 1983Date of Patent: September 29, 1987Assignee: Hoffmann-La Roche Inc.Inventor: Bernhard Merkli
-
Patent number: 4654323Abstract: A novel method and composition are disclosed for the therapeutic and prophylatic treatment of trauma to the skin. In particular, burns, sunburn and frostbite are treated with compounds that have the ability to interfere with the action of calcium calmodulin complex. A preferred compound is trifluoperazine.Type: GrantFiled: August 2, 1985Date of Patent: March 31, 1987Assignee: Bar Ilan UniversityInventor: Rivka Beitner
-
Patent number: 4599226Abstract: Animal tissue and the like having silver sulfadiazine incorporated therein is useful as a covering for burns and/or wounds. The silver sulfadiazine is incorporated in the tissue by soaking the tissue in an ammoniacal silver sulfadiazine solution or suspension. When the silver sulfadiazine is so incorporated in the tissue via an ammonium solution, more silver is found to be present than would normally be expected and the effectiveness of the thus treated tissue as a wound covering increases.Type: GrantFiled: March 1, 1984Date of Patent: July 8, 1986Assignee: Genetic Laboratories, Inc.Inventors: Charles L. Fox, Jr., Shanta M. Modak, Paul Fox
-
Patent number: 4581028Abstract: Infection-resistant materials, and methods of preparing same, suitable for use within the interior of a human or animal body in such forms as vascular grafts prostheses, or other implanted devices. The material is rendered infection-resistant by incorporating therein antimicrobial agents, such as metal salts of sulfonamides and other antimicrobials or antibacterials, such as piperacillin. In particular illustrative embodiments, silver sulfadiazine is complexed by novel techniques with natural or synthetic polymeric materials such as silk, polyester (e.g., Dacron), polyurethane, polytetrafluoroethylene, or silicone-based material, to provide long-term prevention of infections which may otherwise result during, or after, surgery or implantation of a device.Type: GrantFiled: April 30, 1984Date of Patent: April 8, 1986Assignee: The Trustees of Columbia University in the City of New YorkInventors: Charles L. Fox, Jr., Shanta Modak, Keith Reemtsma
-
Patent number: 4579731Abstract: A protective skin matrix is provided which is particularly suited for the protection of burned or wounded patients. The matrix may be either cured, applied in sheets, or painted or sprayed directly onto the burned or wounded patient. The protective skin matrix includes polyvinylpyrrolidone, polyvinylalcohol, and glycerol.Type: GrantFiled: June 19, 1984Date of Patent: April 1, 1986Assignee: Key Pharmaceuticals, Inc.Inventors: Charles L. Fox, Jr., Alec D. Keith, Wallace Snipes
-
Patent number: 4562211Abstract: 2-Substituted-1-(omega-aminoalkoxy)benzenes are prepared and found useful as pharmaceutical agents, particularly as antidepressants.Type: GrantFiled: November 16, 1979Date of Patent: December 31, 1985Assignee: Mitsubishi Chemical Industries, Ltd.Inventors: Ryoji Kikumoto, Akihiro Tobe, Shinji Tonomura, Hidenobu Ikoma
-
Patent number: 4559223Abstract: This invention discloses compositions useful as dentifrices or oral medicaments and capable of inhibiting microbial mouth infections. The compositions contain an effectiveamount of silver and/or zinc sulfadiazine and a suitable carrier. By inhibiting microbial mouth infections, these compositions reduce or eliminate dental caries, plaque formation, gingival destruction, bone and tooth loss. The compositions of this invention may be in the form of liquids such as mouthwashes, pastes such as toothpastes or solids such as chewing gums or coated dental tapes or flosses.Type: GrantFiled: December 6, 1984Date of Patent: December 17, 1985Assignee: Daltex Medical Sciences, Inc.Inventor: Charles L. Fox, Jr.
-
Patent number: 4535078Abstract: An antibacterial composition useful in burn therapy comprises silver sulfadiazine, sodium piperacillin and a physiologically acceptable carrier.Type: GrantFiled: April 6, 1984Date of Patent: August 13, 1985Assignee: The Trustees of Columbia University in the City of New YorkInventors: Charles L. Fox, Jr., Shanta M. Modak
-
Patent number: RE31926Abstract: Compounds of the formula ##STR1## wherein A is phenyl; 4-hydroxy-phenyl; 2- or 3-thienyl; cyclohexyl; cyclohexen-1-yl; cyclohexa-1, 4-dien-1-yl; or 3,4-disubstituted phenyl, where the substituents may be identical to or different from each other and are selected from the group consisting of chlorine, hydroxyl or methoxy; andR is an aliphatic, cycloaliphatic; aromatic or heterocyclic group of diverse types;and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases. The compounds as well as their salts are useful as antibiotics.Type: GrantFiled: September 21, 1982Date of Patent: June 25, 1985Assignee: Boehringer Ingelheim GmbHInventors: Bernd Wetzel, Wolfgang Reuter, Eberhard Woitun, Roland Maier, Uwe Lechner, Hanns Goeth, Rolf Werner